These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29391261)

  • 1. Nanomedicine as a potential approach to empower the new strategies for the treatment of preeclampsia.
    Valero L; Alhareth K; Gil S; Lecarpentier E; Tsatsaris V; Mignet N; Fournier T; Andrieux K
    Drug Discov Today; 2018 May; 23(5):1099-1107. PubMed ID: 29391261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macromolecule nanotherapeutics: approaches and challenges.
    Tyagi P; Santos JL
    Drug Discov Today; 2018 May; 23(5):1053-1061. PubMed ID: 29326081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of preeclampsia: current approach and future perspectives.
    Berzan E; Doyle R; Brown CM
    Curr Hypertens Rep; 2014 Sep; 16(9):473. PubMed ID: 25135649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnological approaches for the treatment of placental dysfunction: recent trends and future perspectives.
    Zhao J; Zhang J; Xu Y; Dong J; Dong Q; Zhao G; Shi Y
    Nanomedicine (Lond); 2023 Nov; 18(26):1961-1978. PubMed ID: 37990993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges.
    Ullah Z; Athar MT; Samad A
    Recent Pat Antiinfect Drug Discov; 2017; 12(2):128-137. PubMed ID: 28990537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-Functionalized Nanoparticles as Efficient Tools in Targeted Therapy of Pregnancy Complications.
    Zhang B; Liang R; Zheng M; Cai L; Fan X
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro toxicity assessment of oral nanocarriers.
    Ciappellano SG; Tedesco E; Venturini M; Benetti F
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):381-401. PubMed ID: 27544694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New perspectives on preeclampsia].
    Méhats C; Miralles F; Vaiman D
    Med Sci (Paris); 2017 Dec; 33(12):1079-1088. PubMed ID: 29261496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine: a new paradigm to overcome drug incompatibilities.
    Abdelkader A; Fathi HA; Hamad MA; Elsabahy M
    J Pharm Pharmacol; 2020 Oct; 72(10):1289-1305. PubMed ID: 32436221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential targets for the treatment of preeclampsia.
    Oyston CJ; Stanley JL; Baker PN
    Expert Opin Ther Targets; 2015; 19(11):1517-30. PubMed ID: 26389556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of preeclampsia with hydroxychloroquine: a review.
    Abd Rahman R; DeKoninck P; Murthi P; Wallace EM
    J Matern Fetal Neonatal Med; 2018 Feb; 31(4):525-529. PubMed ID: 28142291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of therapeutic efficacy of miR-126 with contrast-enhanced ultrasound in preeclampsia rats.
    Yan T; Cui K; Huang X; Ding S; Zheng Y; Luo Q; Liu X; Zou L
    Placenta; 2014 Jan; 35(1):23-9. PubMed ID: 24239158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preeclampsia: the role of angiogenic factors in its pathogenesis.
    Wang A; Rana S; Karumanchi SA
    Physiology (Bethesda); 2009 Jun; 24():147-58. PubMed ID: 19509125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging drugs for preeclampsia--the endothelium as a target.
    Sasser JM; Murphy SR; Granger JP
    Expert Opin Emerg Drugs; 2015; 20(4):527-30. PubMed ID: 26138471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A1M Ameliorates Preeclampsia-Like Symptoms in Placenta and Kidney Induced by Cell-Free Fetal Hemoglobin in Rabbit.
    Nääv Å; Erlandsson L; Axelsson J; Larsson I; Johansson M; Wester-Rosenlöf L; Mörgelin M; Casslén V; Gram M; Åkerström B; Hansson SR
    PLoS One; 2015; 10(5):e0125499. PubMed ID: 25955715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
    Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
    Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kidney in normal pregnancy and preeclampsia.
    Cornelis T; Odutayo A; Keunen J; Hladunewich M
    Semin Nephrol; 2011 Jan; 31(1):4-14. PubMed ID: 21266261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preeclampsia: an update.
    Lambert G; Brichant JF; Hartstein G; Bonhomme V; Dewandre PY
    Acta Anaesthesiol Belg; 2014; 65(4):137-49. PubMed ID: 25622379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pre-eclampsia--a review].
    Haram K; Bjørge L; Guttu K; Bergsjø P
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1437-42. PubMed ID: 10851942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.